Efficacy and safety of rivaroxaban compared with warfarin in patients ...

Patients with CD in ROCKET AF had similar risk of stroke/SE compared with patients without CD. Additionally, there was no interaction ...

Efficacy and safety of rivaroxaban compared with warfarin ... - PubMed

Conclusions: Elderly patients had higher stroke and major bleeding rates than younger patients, but the efficacy and safety of rivaroxaban relative to warfarin ...

Efficacy and Safety of Rivaroxaban Compared With Warfarin Among ...

Elderly patients had higher stroke and major bleeding rates than younger patients, but the efficacy and safety of rivaroxaban relative to warfarin did not ...

Evaluation of the efficacy and safety of rivaroxaban compared to ...

The trial demonstrated that rivaroxaban is as effective as warfarin in terms of thrombus resolution rate, reduction in thrombus size, bleeding risk, and ...

Efficacy and safety of rivaroxaban versus warfarin in the ... - Frontiers

The rivaroxaban group exhibited a higher representation of male patients and an elevated mean BMI compared with the warfarin group. Furthermore, ...

Efficacy and safety of rivaroxaban compared with warfarin in patients ...

Conclusions. In this large randomized-controlled trial, the risk of stroke/systemic embolism and major bleeding/NMCR bleeding was similar ...

Evaluation of the efficacy and safety of rivaroxaban compared to ...

Conclusions: In conclusion, in this randomized controlled trial, we showed that rivaroxaban was non-inferior to Warfarin in thrombus resolution rate, thrombus ...

Safety and Effectiveness of Rivaroxaban Versus Warfarin Across ...

In adults with AF, rivaroxaban compared with warfarin was associated with lower or similar risk of all-cause death, ischemic stroke and transient ischemic ...

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

In conclusion, in this trial comparing a once-daily, fixed dose of rivaroxaban with adjusted-dose warfarin in patients with nonvalvular atrial ...

Efficacy and safety of rivaroxaban vs. warfarin in patients with non ...

Although based on a small number of events, trends of haemorrhagic stroke, intracranial haemorrhage, critical organ bleeding, and fatal bleeding were lower ...

A Comparative Study of the Clinical Benefits of Rivaroxaban and ...

(12) compared the safety and effectiveness of oral anticoagulants in Asian patients with NVAF, and the results showed that rivaroxaban was associated with a ...

Comparative Effectiveness and Safety of Rivaroxaban and Warfarin ...

Patients on rivaroxaban were significantly younger compared to those on warfarin (61 vs. 72 years; p=0.026). However, those on rivaroxaban ...

Safety and efficacy of rivaroxaban compared with warfarin in ...

Conclusions: Real-world experience using rivaroxaban and warfarin in patients after peripheral arterial procedures suggests a comparable safety and efficacy ...

The Safety and Efficacy of Rivaroxaban Compared with Warfarin in ...

Our study suggests a favorable risk–benefit profile of rivaroxaban, with superior efficacy and safety over warfarin in patients with AF and diabetes.

Effectiveness and safety of rivaroxaban versus warfarin in obese ...

Conclusions: Among obese NVAF patients, prescription of rivaroxaban was associated with a reduced risk of SSE and major bleeding compared to warfarin, which ...

Rivaroxaban vs warfarin in high-risk patients with antiphospholipid ...

Rivaroxaban is an effective and safe alternative to warfarin in patients with atrial fibrillation and venous thromboembolism.

Effectiveness and safety of rivaroxaban versus warfarin among ...

Among younger patients with a diagnosis of AF and obesity, rivaroxaban was associated with a 26% lower risk of stroke/SE compared with warfarin over 3 years of ...

Effectiveness and Safety of Rivaroxaban versus Warfarin Among ...

Rivaroxaban was also associated with a significantly lower risk of ischemic stroke, hemorrhagic stroke, and systemic embolism versus warfarin.

Efficacy and Safety of Rivaroxaban versus Warfarin for the ...

Severe bleeding episodes were not observed in any patients in the rivaroxaban group compared with 3 patients (7.14%) in the standard therapy ...

Comparison of the efficacy and safety of new oral anticoagulants ...

Low-dose new oral anticoagulant regimens showed similar overall reductions in stroke or systemic embolic events to warfarin (1·03, 0·84–1·27; p= ...